IRIS
FERRO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.988
EU - Europa 3.321
AS - Asia 1.238
AF - Africa 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.967
IE - Irlanda 1.010
SE - Svezia 854
CN - Cina 583
SG - Singapore 426
UA - Ucraina 380
IT - Italia 348
DE - Germania 251
FI - Finlandia 188
GB - Regno Unito 135
VN - Vietnam 119
IN - India 89
CZ - Repubblica Ceca 39
BE - Belgio 38
RU - Federazione Russa 24
CA - Canada 20
FR - Francia 17
AT - Austria 11
NL - Olanda 6
CH - Svizzera 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
JP - Giappone 3
KG - Kirghizistan 3
PL - Polonia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CL - Cile 2
CO - Colombia 2
LV - Lettonia 2
MA - Marocco 2
RO - Romania 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BO - Bolivia 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
TJ - Tagikistan 1
TR - Turchia 1
TW - Taiwan 1
Totale 8.569
Salva come PNG Salva come JPEG
Città #
Dublin 1.008
Jacksonville 779
Chandler 726
Nyköping 577
Singapore 351
Beijing 278
Ashburn 217
Princeton 179
Dearborn 170
Cambridge 167
Medford 160
Des Moines 131
Ann Arbor 127
Messina 123
Dong Ket 116
Boardman 106
Lancaster 60
Wilmington 48
Woodbridge 48
Hyderabad 41
Jinan 41
San Mateo 40
Pune 37
Brussels 36
Shenyang 34
Brno 30
Catania 29
Nanjing 28
Los Angeles 26
Lappeenranta 22
Haikou 20
Hebei 20
Hangzhou 15
Munich 15
New York 15
Ningbo 15
Seattle 15
Taizhou 13
Ottawa 12
Fuzhou 11
Vienna 11
Zhengzhou 11
Francofonte 10
Guangzhou 10
Houston 9
Norwalk 9
Tianjin 9
Washington 9
Olomouc 8
Taiyuan 8
Helsinki 7
Nanchang 7
Nicotera 7
Changsha 6
Jiaxing 6
Saint Petersburg 6
Auburn Hills 5
Chicago 5
Clearwater 5
Falls Church 5
Kunming 5
Leawood 5
Brooklyn 4
Hefei 4
London 4
Milan 4
Montréal 4
Rome 4
Shanghai 4
Tunis 4
West Jordan 4
Ardabil 3
Augusta 3
Bishkek 3
Borghetto Santo Spirito 3
Bratislava 3
Brugherio 3
Como 3
Ho Chi Minh City 3
Mcallen 3
Mumbai 3
Phoenix 3
Siena 3
Alghero 2
Bogotá 2
Carugate 2
Durban 2
Fiorenzuola D'arda 2
Furci Siculo 2
Guspini 2
Hanover 2
Kharkov 2
Lanzhou 2
Larne 2
Leonforte 2
Monmouth Junction 2
Monselice 2
Naples 2
Novokuznetsk 2
Nuremberg 2
Totale 6.155
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 202
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 142
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 104
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 96
AMPA receptor antagonists: Synthesis and pharmacological evaluation 93
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 92
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 82
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 81
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 81
Graphene Quantum Dots Based Systems As HIV Inhibitors 81
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 80
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 77
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 76
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 74
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 73
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 70
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 70
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 68
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 67
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 66
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 66
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 65
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 65
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 65
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 65
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 65
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 65
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 64
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 64
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 64
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 64
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 63
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 63
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 63
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 63
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 62
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 62
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 61
Antiretroviral strategy using multi-target agents 61
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 60
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 60
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 60
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 59
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 58
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 58
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 58
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 58
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 58
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 57
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 57
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 57
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 57
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 56
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 56
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 56
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 56
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 55
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 55
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 55
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 55
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 55
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 54
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 54
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 54
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 53
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 53
Synthesis of new potential HIV-1 integrase inhibitors 53
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 53
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 53
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 53
Pharmacophore-based design of HIV-1 integrase inhibitors 52
Progettazione e Sintesi di Nuovi Inibitori dell'Integrasi dell'HIV-1 52
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 52
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 52
Progettazione e sintesi di antagonisti non competitivi del recettore NR2B/NMDA 52
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 52
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 51
Rational design, synthesis and SAR of 1,3-dihydro-benzimidazolone analogues as new anti-HIV agents 51
HIV-1 integrase inhibitors as anti-AIDS agents: Structure-Activity Relationships (SAR) of new diketo acids and analogs 51
Computational studies and synthetic approaches for the identification of new protein-protein interaction inhibitors (PPI) 51
Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors. 51
ISOQUINOLINE-SULFONAMIDES AS A CLASS OF POTENT AND SELECTIVE CARBONIC ANHYDRASE INHIBITORS 51
Analysis of Italian regulations on pathways of care for patients in a vegetative or minimally conscious state 51
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 50
Pharmacophore based design of HIV-1 integrase inhibitors 50
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 50
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 50
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 50
New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action 50
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 50
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 50
Graphene Quantum Dots based systems as HIV Inhibitors 50
Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors 49
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 49
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 49
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 49
N-Substituted Isoquinoline Derivatives as Potential AChE Inhibitors 49
New Indole derivatives as NMDA/NR2B rrceptor antagonists: design, synthesis and pharmacological properties 48
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 48
New potent and selective carbonic anhydrase inhibitors: synthesis, biological evaluation and X-ray studies 48
Totale 6.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020721 0 0 0 0 0 0 169 125 20 190 209 8
2020/20211.179 130 6 198 52 54 123 17 142 38 142 85 192
2021/20221.060 10 161 25 48 38 11 81 39 28 11 258 350
2022/20232.901 242 254 143 218 212 297 54 148 1.232 8 74 19
2023/2024682 57 102 50 134 56 124 7 16 1 56 14 65
2024/2025588 59 46 59 181 109 123 11 0 0 0 0 0
Totale 8.748